Kemp Dolliver's Stock Ratings

Brookline Capital Analyst

Kemp Dolliver is an analyst at Brookline Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/22/2024

Overall Average Return

-3.90%

Smart Score

37.2%

Overall Average Return Percentile

28th

Number of Ratings

20
Buy NowGet Alert
07/22/2024IBIOBuy Now
iBio
$2.2063.64% → $3.6Initiates → BuyGet Alert
05/15/2024DAREBuy Now
Dare Bioscience
$3.69-18.59% → $36UpgradeHold → BuyGet Alert
04/17/2024DAREBuy Now
Dare Bioscience
$3.69——DowngradeBuy → HoldGet Alert
03/19/2024FUSNBuy Now
Fusion Pharmaceuticals
———DowngradeBuy → HoldGet Alert
01/25/2024OTLKBuy Now
Outlook Therapeutics
$8.03-80.45% → $31.4UpgradeHold → BuyGet Alert
12/21/2023PNTBuy Now
POINT Biopharma Global
——$27 → $12.5DowngradeBuy → HoldGet Alert
12/19/2023CYCCBuy Now
Cyclacel Pharmaceuticals
$1.67——DowngradeBuy → HoldGet Alert
12/04/2023ONCTBuy Now
Oncternal Therapeutics
$7.00-71.43% → $40UpgradeHold → BuyGet Alert
11/30/2023LNTHBuy Now
Lantheus Holdings
$114.14-12.39% → $100Initiates → BuyGet Alert
10/17/2023EYENBuy Now
Eyenovia
$1.18580.85% → $8Initiates → BuyGet Alert
10/12/2023EDSABuy Now
Edesa Biotech
$4.801087.5% → $57MaintainsBuyGet Alert
09/06/2023PROCBuy Now
Procaps Gr
$3.0846.1% → $4.5DowngradeBuy → HoldGet Alert
05/18/2023GNLXBuy Now
Genelux
$2.201036.36% → $25Initiates → HoldGet Alert
05/01/2023NHWKBuy Now
NightHawk Biosciences
———DowngradeBuy → HoldGet Alert
04/04/2023ONCTBuy Now
Oncternal Therapeutics
$7.00——DowngradeBuy → HoldGet Alert
01/13/2023ECORBuy Now
electroCore
$5.88-78.74% → $18.75Initiates → BuyGet Alert
12/16/2022EDSABuy Now
Edesa Biotech
$4.80170.83% → $13MaintainsBuyGet Alert
10/21/2022SCYXBuy Now
SCYNEXIS
$2.14273.83% → $8Assumes → BuyGet Alert
03/10/2022VRCABuy Now
Verrica Pharmaceuticals
$7.04184.09% → $20Initiates → BuyGet Alert
02/02/2022ICCMBuy Now
Icecure Medical
$0.70707.14% → $5.65Initiates → BuyGet Alert
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free